Cidara Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
CDTX on Nasdaq
Location
6310 Nancy Ridge Drive, Suite 101, San Diego, CA

Insiders trading volume in the past year

Cidara Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ra Capital Management, L.P. Director $35.5M Nov 26, 2024
Jeffrey Stein President & CEO, Director $1.12M +$106K +10.4% Sep 30, 2024
Taylor Sandison Chief Medical Officer $268K -$24.6K -8.39% Sep 30, 2024
Preetam Shah Chief Financial Officer $232K -$12.7K -5.19% Sep 30, 2024
Shane Ward Coo & Clo $220K -$13.7K -5.87% Sep 30, 2024
Paul Daruwala Chief Operating Officer $210K Sep 12, 2022
Leslie Tari Chief Scientific Officer $208K -$24.7K -10.6% Sep 30, 2024
Brady Johnson Vice President, Finance $56.3K Mar 31, 2022
Carin Canale-Theakston Director Dec 17, 2024
David L. Gollaher Director Jun 22, 2023
Bonnie L. Bassler Director Dec 17, 2024
James Merson Director Jul 18, 2024
Ryan Spencer Director Jul 18, 2024
Chrysa Mineo Director Dec 17, 2024
Timothy R. Franson Director Jun 22, 2023
Daniel D. Burgess Director Dec 17, 2024
Theodore R. Schroeder Director Dec 17, 2024
Laura Tadvalkar Director Jul 18, 2024

Recent Insider Transactions by Companies or Individuals for Cidara Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.